Human anti-Rh(D) monoclonal antibodies and methods of use of antibodies
in immunotherapy
    2.
    发明授权
    Human anti-Rh(D) monoclonal antibodies and methods of use of antibodies in immunotherapy 失效
    人抗Rh(D)单克隆抗体和抗体在免疫治疗中的使用方法

    公开(公告)号:US5653978A

    公开(公告)日:1997-08-05

    申请号:US470141

    申请日:1995-06-06

    摘要: The present invention provides human monoclonal antibodies having the following essential characteristics: (a) binding to Rh(D) antigen, but not C, c, E or e antigens of the Rh blood group system; (b) being IgG3 proteins; (c) having kappa light chains; (d) being of the allotype G3m(21); (e) binding to D.sup.u cells by an indirect antiglobulin test; (f) binding to D.sup.IV, D.sup.V and D.sup.VII variant antigens; and (g) not binding to D.sup.VI or D.sup.B variant antigens, which may be employed for Rh-typing of red blood cells and passive immunization to prevent hemolytic disease of the newborn. Such a monoclonal antibody is exemplified by the monoclonal antibody of cell line ECACC 87091606 deposited at the European Collection of Animal Cell Cultures, Public Health Laboratory Service Center for Applied Microbiology and Research, Porton Down, Salisbury, Wiltshire, SP4, OJG, England, on Sep. 16, 1987.

    摘要翻译: 本发明提供具有以下基本特征的人单克隆抗体:(a)与Rh血型系统的Rh(D)抗原但不与C,c,E或e抗原结合; (b)为IgG3蛋白; (c)具有κ轻链; (d)是同型G3m(21); (e)通过间接抗球蛋白试验与Du细胞结合; (f)与DIV,DV和DVII变体抗原的结合; 和(g)不与DVI或DB变体抗原结合,其可用于红细胞的Rh分型和被动免疫以预防新生儿的溶血性疾病。 这样的单克隆抗体的例子是保藏在European Collection of Animal Cell Cultures,Public Health Laboratory Service Center for Applied Microbiology and Research,Porton Down,Salisbury,Wiltshire,SP4,OJG,England的细胞系ECACC 87091606的单克隆抗体上, 1987年9月16日。

    Human anti-RH(D) monoclonal antibodies, cell lines and methods of use of
antibodies in immunoassays
    3.
    发明授权
    Human anti-RH(D) monoclonal antibodies, cell lines and methods of use of antibodies in immunoassays 失效
    人类抗RH(D)单克隆抗体,细胞系和免疫测定中抗体的使用方法

    公开(公告)号:US5496548A

    公开(公告)日:1996-03-05

    申请号:US45244

    申请日:1993-04-13

    摘要: The present invention provides human monoclonal antibodies having the following essential characteristics: (a) binding to Rh(D) antigen, but not C, c, E or e antigens of the Rh blood group system; (b) being IgG3 proteins; (c) having kappa light chains; (d) being of the allotype G3m(21); (e) binding to D.sup.u cells by an indirect antiglobulin test; (f) binding to D.sup.IV, D.sup.V and D.sup.VII variant antigens; and (g) not binding to D.sup.VI or D.sup.B variant antigens, which may be employed for Rh-typing of red blood cells and passive immunization to prevent hemolytic disease of the newborn. Such a monoclonal antibody is exemplified by the monoclonal antibody of cell line ECACC 87091606 deposited at the European Collection of Animal Cell Cultures, Public Health Laboratory Service Center for Applied Microbiology and Research, Porton Down, Salisbury, Wiltshire, SP4, OJG, England of Sep. 16, 1987.

    摘要翻译: 本发明提供具有以下基本特征的人单克隆抗体:(a)与Rh血型系统的Rh(D)抗原但不与C,c,E或e抗原结合; (b)为IgG3蛋白; (c)具有κ轻链; (d)是同型G3m(21); (e)通过间接抗球蛋白试验与Du细胞结合; (f)与DIV,DV和DVII变体抗原的结合; 和(g)不与DVI或DB变体抗原结合,其可用于红细胞的Rh分型和被动免疫以预防新生儿的溶血性疾病。 这样的单克隆抗体的例子是保藏在European Collection of Animal Cell Cultures,Public Health Laboratory Service Center for Applied Microbiology and Research,Porton Down,Salisbury,Wiltshire,SP4,OJG,England of Sep的细胞系ECACC 87091606的单克隆抗体 1987年。

    Human anti-Rh (D) monoclonal antibodies
    4.
    发明授权
    Human anti-Rh (D) monoclonal antibodies 失效
    人类抗Rh(D)单克隆抗体

    公开(公告)号:US5665356A

    公开(公告)日:1997-09-09

    申请号:US477552

    申请日:1995-06-07

    摘要: The present invention provides human monoclonal antibodies having the following essential characteristics: (a) binding to Rh(D) antigen, but not C, c, E or e antigens of the Rh blood group system; (b) being IgG1 proteins; (c) having kappa light chains; (d) being Glm(3) or Glm(1,17) allotype; (e) binding to D.sup.u cells by an indirect antiglobulin test; (f) binding to D.sup.IV, D.sup.V and D.sup.VII variant antigens; and (g) not binding to D.sup.VI or D.sup.B variant antigens, which may be employed for Rh-typing of red blood cells and passive immunization to prevent hemolytic disease of the newborn. Such a monoclonal antibody is exemplified by the monoclonal antibodies of cell lines ECACC 87091605 and 87091604 deposited at the European Collection of Animal Cell Cultures, Public Health Laboratory Service Center for Applied Microbiology and Research, Porton Down, Salisbury, Wiltshire, SP4, OJG, England on Sep. 16, 1987.

    摘要翻译: 本发明提供具有以下基本特征的人单克隆抗体:(a)与Rh血型系统的Rh(D)抗原但不与C,c,E或e抗原结合; (b)为IgG1蛋白; (c)具有κ轻链; (d)为Glm(3)或Glm(1,17)异型; (e)通过间接抗球蛋白试验与Du细胞结合; (f)与DIV,DV和DVII变体抗原的结合; 和(g)不与DVI或DB变体抗原结合,其可用于红细胞的Rh分型和被动免疫以预防新生儿的溶血性疾病。 这样的单克隆抗体的例子是保藏在欧洲动物细胞培养物公共卫生实验室,应用微生物学与研究公共卫生实验室服务中心,威尔特郡,索尔兹伯里,Porton Down的公开的ECACC 87091605和87091604的单克隆抗体,SP4,OJG,England 1987年9月16日。

    Human anti-RH(D) monoclonal antibodies reagents and hybridomas and
methods of RH typing using anti-RH(D) monoclonal antibodies and reagents
    5.
    发明授权
    Human anti-RH(D) monoclonal antibodies reagents and hybridomas and methods of RH typing using anti-RH(D) monoclonal antibodies and reagents 失效
    人类抗RH(D)单克隆抗体试剂和杂交瘤和使用抗RH(D)单克隆抗体和试剂进行RH分型的方法

    公开(公告)号:US5487891A

    公开(公告)日:1996-01-30

    申请号:US57560

    申请日:1993-05-06

    摘要: The present invention provides human monoclonal antibodies having the following essential characteristics: (a) binding to Rh(D) antigen, but not C, c, E or e antigens of the Rh blood group system; (b) being IgGl proteins; (c) having kappa light chains; (d) being Glm(3) or Glm(1,17) allotype; (e) binding to D.sup.u cells by an indirect antiglobulin test; (f) binding to D.sup.IV, D.sup.V and D.sup.VII variant antigens; and (g) not binding to D.sup.VI or D.sup.B variant antigens, which may be employed for Rh-typing of red blood cells and passive immunization to prevent hemolytic disease of the newborn. Such a monoclonal antibody is exemplified by the monoclonal antibodies of cell lines ECACC 87091605 and 87091604 deposited at the European Collection of Animal Cell Cultures, Public Health Laboratory Service Center for Applied Microbiology and Research, Porton Down, Salisbury, Wiltshire, SP4, OJG, England on 16th September 1987.

    摘要翻译: 本发明提供具有以下基本特征的人单克隆抗体:(a)与Rh血型系统的Rh(D)抗原但不与C,c,E或e抗原结合; (b)为IgG1蛋白; (c)具有κ轻链; (d)为Glm(3)或Glm(1,17)异型; (e)通过间接抗球蛋白试验与Du细胞结合; (f)与DIV,DV和DVII变体抗原的结合; 和(g)不与DVI或DB变体抗原结合,其可用于红细胞的Rh分型和被动免疫以预防新生儿的溶血性疾病。 这样的单克隆抗体的例子是保藏在欧洲动物细胞培养物公共卫生实验室,应用微生物学与研究公共卫生实验室服务中心,威尔特郡,索尔兹伯里,Porton Down的公开的ECACC 87091605和87091604的单克隆抗体,SP4,OJG,England 1987年9月16日。